Market Signals

OIL ENDS WEEK HIGHER ON RENEWED US-IRAN STRIKES, DIESEL HITS RECORD - ECONOMICTIMES

HOW TO EARN $500 A MONTH FROM NETAPP STOCK AHEAD OF Q1 EARNINGS - YAHOO

TORRID Q2 EARNINGS CALL HIGHLIGHTS - YAHOO

CHIPMAKER AMBARELLA POSTS MIXED FISCAL Q2 EARNINGS REPORT - YAHOO

TRUMP SAYS MILITARY CONFLICT IN IRAN IS 'SMALL POTATOES FOR US' - NBC

WATCH: ILLEGAL ALIEN BUSTED IN BATTLEGROUND STATE AFTER ALLEGEDLY COMMITTING VOTER FRAUD - FOX

OPENAI’S ROGUE AGENTS KEEP ESCAPING, WITH NO FORMAL PROCESS TO INVESTIGATE THEM - TECH

BENCHMARK 2023-V2 MORTGAGE TRUST 8-K: Other Events (Major) (+Financial Statements and Exhibits)

BMO 2023-C6 MORTGAGE TRUST 8-K: Other Events (Major) (+Financial Statements and Exhibits)

BMO 2023-5C2 MORTGAGE TRUST 8-K: Other Events (Major) (+Financial Statements and Exhibits)

BENCHMARK 2023-B38 MORTGAGE TRUST 8-K: Other Events (Major)

BMO 2023-C7 MORTGAGE TRUST 8-K: Other Events (Major) (+Financial Statements and Exhibits)

BMO 2025-5C9 MORTGAGE TRUST 8-K: Other Events (Major) (+Financial Statements and Exhibits)

$LAMR (LAMAR ADVERTISING CO/NEW) — 8-K: Lamar declares $1.65 quarterly dividend; 2026 distributions seen at least $6.50 per share

$RJF (RAYMOND JAMES FINANCIAL) — 8-K: Raymond James adds Will Weatherford to board effective Dec. 15, 2026

$FLNC (FLUENCE ENERGY) 8-K: CEO/CFO/Director Departure or Appointment (+Other Events (Major))

$VRTX (VERTEX PHARMACEUTICALS INC /..) 8-K: CEO/CFO/Director Departure or Appointment

$HYMC (HYCROFT MINING HOLDING) — 8-K: Hycroft adds four mining veterans to board, names Richard O’Brien Lead Independent Director

$RMD (RESMED) 8-K: Other Events (Major)

$UCB (UNITED COMMUNITY BANKS) — 8-K: United closes $2.0 billion sale of Navitas equipment finance business to Wafra

$MRNA (MODERNA) — 8-K: Moderna proposes $2.0 billion convertible senior notes due 2032 private placement

$YUM (YUM BRANDS) — 8-K: Yum! completes Pizza Hut sale to LongRange for $1.5 billion

$MPB (MID PENN BANCORP) — 8-K: Mid Penn appoints former TD Bank CEO Gregory Braca to board effective Sept 16, 2026

BANK 2020-BNK29 8-K: Other Events (Major)

BANK 2021-BNK32 8-K: Other Events (Major)

BANK 2021-BNK35 8-K: Other Events (Major)

BANK 2022-BNK44 8-K: Other Events (Major)

WATCHDOG REPORT ALLEGES MISCONDUCT BY TRUMP’S FORMER LABOUR SECRETARY - ALJAZEERA

HOW MICRON TECHNOLOGY (MU) IS SHAPING THE AI LANDSCAPE - YAHOO

$APH (AMPHENOL CORP /DE/) 8-K: Other Events (Major)

SILVER PRICE TODAY, THURSDAY, SEPTEMBER 3, 2026: SILVER PRICES RISE FOLLOWING SHORT-LIVED AIRSTRIKES - YAHOO

$CACC (CREDIT ACCEPTANCE) 8-K: CEO/CFO/Director Departure or Appointment

$RMBS (RAMBUS) 8-K: CEO/CFO/Director Departure or Appointment

KKR FS INCOME TRUST 8-K: Other Events (Major) (+Financial Statements and Exhibits)

KKR FS INCOME TRUST SELECT 8-K: Other Events (Major) (+Financial Statements and Exhibits)

KENNEDY LEWIS CAPITAL CO 8-K: Other Events (Major) (+Financial Statements and Exhibits)

8-K: Net Asset Value totals $1.31 billion as of July 31, 2026

OPINION: GOOGLE'S LATEST ANTITRUST RULING IS A BIG WIN FOR ALPHABET INVESTORS - YAHOO

WONDERFUL SECURES $550M TO SCALE ENTERPRISE AI PLATFORM - YAHOO

$NVDA (NVIDIA) 8-K: Other Events (Major) (+Financial Statements and Exhibits)

$FDXF (FEDEX FREIGHT HOLDING COMPANY) 8-K: Other Events (Major)

8-K: FHLB Des Moines names Wil W. Osborn president and CEO effective October 1, 2026

$BDN (BRANDYWINE REALTY TRUST) 8-K: Other Events (Major)

$AVXL (ANAVEX LIFE SCIENCES) — 8-K: Anavex regains full Nasdaq compliance after filing overdue 10-Qs

KKR ENHANCED US DIRECT LENDING FUND-L INC. 8-K: Other Events (Major)

$SAIA (SAIA) — 8-K: Saia Q3-to-date LTL tonnage per workday up 8.3% on 1.0% shipment growth

$HLMN (HILLMAN SOLUTIONS) — 8-K: Hillman closes $315M Kanebridge buy, adding 44,000 fastener SKUs

$LQDA (LIQUIDIA) — 8-K: FDA grants Fast Track to YUTREPIA for systemic sclerosis Raynaud’s

$LBRX (LB PHARMACEUTICALS) — 8-K: LB Pharmaceuticals appoints Joseph Miller as CFO ahead of NOVA-2 readout

$APVO (APTEVO THERAPEUTICS) — 8-K: Mipletamig triplet shows 93% clinical benefit rate in TP53-mutated frontline AML